Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

RXi Pharmaceuticals Corp

+ Add to Watchlist

RXII:US

0.7287 USD 0.0037 0.51%

As of 20:10:00 ET on 04/20/2015.

Company Profile for RXi Pharmaceuticals Corp (RXII)

RXi Pharmaceuticals Corp. is a biotechnology company focused on discovering, developing and commercializing therapies addressing major unmet medical needs using RNAi-targeted technologies. The Company's proprietary RNA interference ("RNAi"), is a naturally occurring cellular mechanism that interferes with or silences expression of targeted disease-associated genes.

Contact Information

RXi Pharmaceuticals Corp

60 Prescott Street
Worcester, MA 01605
United States
Phone: 1-508-767-3861

Key Executives for RXi Pharmaceuticals Corp (RXII)

Geert CauwenberghPresident/CEO/Acting CFOPamela A PavcoChief Development Officer

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil